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1. Introduction
Benzimidazole is an aromatic bicyclic heterocyclic ring 
system. It contains benzene and imidazole ring fused 
together at 4 and 5 position (Palit et al., 2016).  They show 
both acidic and basic properties due to amphoteric nature 
of nitrogen atoms (Tahlan et al., 2019). It is a privileged 
macromolecule and entitled pharmacophore in medicinal 
chemistry. It is associated with various pharmacological 
and pharmacodynamic properties. Literature explored that 
within benzimidazole derivatives, 2-substitued compounds 
are identified to be pharmaceutically more effective 
and hence the pattern and chemistry of 2-substitued 
benzimidazoles become probable field of research 
(Chaudhari et al., 2018). This moiety (1) is of choice 
because of many pharmacological properties. Existence 
of benzimidazole scaffold in diverse group of biological 
agents such as antimicrobial, antiviral, antiparasitic, 
antihypertensive, anticancer, CNS stimulant as well as 
antidepressants has made it useful for the progression of 
many more therapeutic agents (Salahuddin et al., 2017). In 
1960, Fort et al. described benzimidazole as proton pump 
inhibitors. Chemistry and evaluation of various substituted 
benzimidazole derivatives reported the invention of 
omeprazole, lansoprazole, rabeprazole, timoprazole 
and pantoprazole (Singh et al., 2012). Thiabendazole, 
mebendazole, albendazole, mebendazoleare widely used 
anthelmintic FDA approved drugs (2) which are currently 
available in market containing benzimidazole scaffold in 
their structure (Kohler et al., 2001).
Benzimidazole (1)
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FDA Approved Drugs (2)
2. Chemistry
2.1. General Synthesis of benzimidazole
Benzimidazole is synthesized from o-phenylenediamine and 
different aromatic acids (3). In this method, the diamine is 
initially refluxed with aromatic acid. The corresponding acid 
is converted into benzimidazole (Vineet and Amrita, 2017).
(3)
A wide range of benzimidazoles were synthesized by 
condensation of o-phenylene diamine with aldehydes to get 
2 –substituted benzimidazoles (4) (Alaqeel, 2017).
(4)
The formation of benzimidazole was done by reacting aryl 
aldehydes with aqueous solution of sodiumbisulphite (5). 
The adduct of bisulphite was formed which was filtered and 
dried. O-phenylene diamine in DMF was added in adduct 
and heated for longer hours at high temperature, which was 
then cooled, filtered and recrystallized.
(5)
3. Pharmacological Activites of Benzimidazole
(6) 
3.1. Anti-Bacterial Activity
Benzimidazole derivatives during literature survey found 
that, 2-substituted analogues are more dynamic and hence 
composition and synthesis of 2-substituted compounds  are 
remarkable sector of research (Tahlan et al., 2019). Various 
1-(substituted-methyl)-2(substituted-phenyl) benzimidazole 
derivatives were synthesized and reported for their 
antibacterial activity against bacterial strains of  S. aureus, B. 
pumillus and P. aeruginosa, Compound (7a) revealed most 
potent antibacterial activity (Enumula et al., 2014). 
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Ghoneium et al. reported 2-(4-aminophenyl) sulphonyl 
derivatives of benzimidazole and screened for antimicrobial 
activity against E. coli bacterial strain by using disc diffusion 
method. All compounds showed antimicrobial activity (7b).
Various new benzamide benzimidazole compounds were 
manufactured using reaction through mannich procedure and 
assessed for their antimicrobial activity against P. aeruginosa, 




benzimidazol-1-ylmethyl]-benzamide (7c) prevailed to be 
much productive antimicrobial compounds. Furthermore, in 
simulated studies were also done to define the interface of the 
suitable analogue with protein of microbe (Sethi et al., 2016).




Fungal infections invade our tissues and spread to organs 
and affects the whole body that results in thoughtful 
attention towards new discovery and development of 
antifungal drugs. The invention of drug ketoconazole in 
1981 by Janssen Pharmaceutical Ltd. to the search for new 
secured and competentagents (Keshav & Wakode, 2017).
A series of novel N-(benzimidazol-1-ylmethyl)-4-
chlorobenzamide derivatives were synthesized by mannich 
reaction and were confirmed by spectrometry and analytical 
techniques. Further these derivatives were also screened for 
their in vitro antimicrobial activity against some of the fungal 
strains, gram negative and gram-positive bacterial strains 
and also for anti-inflammatory potential. In silico studies 
were also done to show the linkage of the target compounds 
with protein of microbe. It was found that derivative (8) 
was found to be the most suitable antimicrobial compound 
among the manufactured derivatives (Sethi et al., 2018).
(8)
3.3. Anti-Ulcer Activity
Gastric acid plays an important role in gastrointestinal 
functions, including proper digestion, and defence against 
various infections. However, improper balance of acid release 
leads to various physiological actions that includes Acid 
reflux, indigestion and stomach ulcers (Olbe et al., 2003). 
Numerous2-[(difluro methoxy-2-pyridyl) methyl sulfinyl]-
5-difluro methoxy benzimidazole substituents and were 
evaluated for antiulcer activity (9) and compounds were 
found to exhibit good antiulcer activity (Patil et al., 2010).
(9)
3.4. Anti-Inflammatory and Analgesic Activity
Some biological synthesized compounds having thiophene 
nucleus were decided to test for anti-inflammatory activity 
and compared with standard drug diclofenac sodium. The 
compounds (10a) showed significant effects when compared 
with standard drug (Suresh et al., 2011).
A series of [1-(N-substituted amino) methyl]-2 
ethyl benzimidazole derivatives (10b) were found to 
have remarkable analgesic and anti-inflammatory action 
(Mariappan et al., 2011).
R= Cinnamaldehyde, m-nitrobenzaldehyde, m-methoxybenzaldehyde
(10a)
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NR1R2= Piperidino, 3,4-dichloroanilino, 4-floroanilino, 4-bromoanilino
(10b)
New substituted benzimidazole analogues were reported 
and evaluated for analgesic and anti-inflammatory activity 
by biological screening followed by antibacterial activity. 
These derivatives (10c) revealed prominent analgesic and 
anti-inflammatory activity (Gaud et al., 2011). 
R1= OH, NH2R2= CH3,Cl  
(10c)
3.5. Anthelmintic Activity
Benzimidazole in parasitic infections was noticed after 
the invention of drug piperazine by Industry of Imperial 
Chemistry in the era of sixties (McFarland, 1972). The result 
of action of drug thiabendazole against various parasitic 
infections of both humans and various pet animals that 
gave a boost in new period of time to design new effective 
anthelmintic. Various benzimidazole-based wide range 
anthelmintic derivatives of azoles came as marketed drugs 
that respond by restraining the formation of micro-tubule 
like flubendazole, cyclobendazole, mebendazole, oxfendazole, 
nocodazole, albendazole (Salahuddin et al., 2012). 
Some of 2-substituted benzimidazole compounds 
(11a-11b) that were screened for their anthelmintic 
activity were reported. All synthesized compounds showed 
significant anthelmintic activity. Amongst all prepared 
2-substituted benzimidazole molecules, compound (11b) 
revealed greatest anthelmintic activity (Palit et al., 2016). 
The paralysis and death time were recorded and compared 




R 1 = R 2 = R 3 = H R 4 = C H 2 - C H 2 -
N(CH3)2
3.6. Anticancer Activity
Cancer has turned out to be tougher to crack than everyone 
ever hoped. Major research has been concluded towards 
the discovery of various anti cancer therapies, including 
radiation therapy and chemotherapy. The mustard moiety 
of nitrogen molecule, a substituted benzimidazole ring, 
and an aromatic acid side chain containing alkane, were 
combined in a single molecule and synthesized which all 
might be liable for its chemotherapeutic action (Enumula 
et al., 2017). All 2-substituted compounds(12a) were 
characterized and subjected to anti-cancer activity against 
various cell lines of human hepato-cellular carcinogenic cell 
lines (HEPG2), Human Breast adenocarcinoma cell lines 
(MCF7) and colon carcinoma cell lines (HCT 116).
Some of the effective benzimidazole derivatives were 
screened for their antitumor activity and were also examined 
and checked by various spectrophotometric methods like 
IR, 13CNMR, H1NMR and analyzed for their antineoplastic 
activity against 60 different cancer cell lines. Among them 
12b and 12c showed positive result against cell lines and 12 
c compound was found to be more efficient because of their 
electron donating group substitution (Morcosset et al., 2020).
Nitrogen mustard alkylating agent
(12a)
R = 2,4 dichloro (12b) R = 3,4,5 trimethoxy (12c)
3.7. Anticonvulsant Activity
Gopal et al., synthesized series of 2-mercaptobenzimidazoles 
which were evaluated for their anti-convulsant action and most 
of these compounds (13) were found to be more efficient.
(13)
 3.8. Antihistaminic Activity
Histamine is a significant neurochemical that effects 
diverse physiological and patho physiological actions 
ISSN No.: 2321-2217(Print) ISSN No.: 2321-2225(Online); Registration No. : CHAENG/2013/50088
Swikriti et al., J. Pharm. Tech. Res. Management Vol. 8, No. 1 (2020) p.27
in the body via activation of various receptors (Hough, 
2001). Histamineis involved in inflammatory and various 
allergic reactions, gastric acid secretion, as well as in neuro-
chemical release. The substituted benzimidazole (14a-14b) 
like bilastine, astemizole, mizolastine, emedastine, and 
clemizole, are performing an important role as good anti-
histaminic antagonists. Some drugs were selected as good 
antagonist at receptor of histamine for the treatment of 
allergic conjunctivitis and urticaria (Walia et al., 2011).
Histamine has a pathological role in maintaining the release 
of gastric juice in the stomach, it activates the parietal cells 
to release hydrochloric acid. In the 1970’s, it was testified 
that H2receptor antagonists blocked the action of histamine 
secretion in the body (Anand & Wakode, 2017). These 
drugs were active against the action of histamine on various 
cells (specifically H2- receptors) in the stomach and limit the 






Viral infections threaten the human health including 
the immune system. Research has been done towards the 
invention of some related drugs of benzimidazole (15) against 
human herpes simplex virus, human immunodeficiency 
virus, and hepatitis B and C virus. An antiviral drug called 
Maribavir is a selective, ribosyl benzimidazole, which is used 
for the treatment of HCMV disease in blood stem cell. Thus, 
the benzimidazole nucleus can produce effective, secured 
and more novel drugs that fulfill the demanding urge of 
population with viral infections. Sharma et al. synthesized 
[2-(substitutedphenyl)-benzimidazol-1-yl]-pyridine-3-yl-
methanones.These compounds showed great activity on 
viral strains (Sharma et al., 2012).
(15)
R1 R2 R3 R4 R5
NO2 H H H H
COOH H H H H
OCH3 H H H H
3.10. Antioxidant Activity  
New derivatives of benzimidazole were synthesized by the 
reaction of o-phenylenediamine with different aromatic 
aldehydes and benzoic acid. The novel analogues were 
characterized by FTIR and 1HNMR techniques. The 
antioxidant assay was carried out using ABTS and DPPH 
method. Compound (16a) and (16b) showed good 
antioxidant activity when compared with Ascorbic acid 
(Singh & Parle, 2020).
 (16a)                                           (16b)
Conclusion
Benzimidazoles have played great role in discovery of drug 
and development. Huge attempt has been done towards 
benzimidazole heterocyclic-based organic compounds with 
great excellence that resulted in drugs with enormous biological 
activity. Therapeutic drugs containing benzimidazole nucleus 
are used in building of drugs that serve to be an active area of 
research. The novel experiments as well as advanced theory 
have been explored and used to discover various newly 
synthesized drugs in the future. We hopefully assume that this 
article will make a source that will lead to discovery of new 
opportunities for all researchers interested in benzimidazole-
based heterocyclic medicinal chemistry.
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